AI Drug Discovery Startup Valo Raises $190 Million And Unveils Cancer Therapy Programs

The Boston-based company aims to accelerate the drug discovery process for cancer therapies that are both more effective and less toxic.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive